Familial adenomatous polyposis

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
Status:
Recruiting
Last Changed:
Jan 16, 2019
First Changed:
Jan 16, 2019
Disease(s):
Familial Adenomatous Polyposis
Intervention(s):
Eicosapentaenoic acid free fatty acid (EPA-FFA)Placebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Status:
Terminated
Last Changed:
Nov 3, 2014
First Changed:
Jan 3, 2008
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
CelecoxibPlacebo

Connect. Empower. Inspire.